Bio-Rad Laboratories, Inc. BIO.B Life Science — Depreciation, Depletion and Amortization
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s life science — depreciation, depletion and amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s life science — depreciation, depletion and amortization?
- Bio-Rad Laboratories, Inc. (BIO.B) reported life science — depreciation, depletion and amortization of $18.3M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s life science — depreciation, depletion and amortization changed year-over-year?
- Bio-Rad Laboratories, Inc.'s life science — depreciation, depletion and amortization increased by 7.6% year-over-year, from $17M to $18.3M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s life science — depreciation, depletion and amortization?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s life science — depreciation, depletion and amortization has grown at a 8.2% compound annual growth rate (CAGR), from $54.8M to $75M.
- What does life science — depreciation, depletion and amortization mean?
- The non-cash cost representing the wear and tear or expiration of assets used in the Life Science segment.
- How do you interpret life science — depreciation, depletion and amortization?
- An increase may indicate significant recent capital investment or high levels of acquired intangible assets.
- How does life science — depreciation, depletion and amortization compare across companies?
- Standard non-cash expense metric used to reconcile net income to cash flow.